|
|
Volumn 5, Issue 9, 2013, Pages 919-921
|
|
Interview: Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOSUPPRESSIVE AGENT;
ANTIGEN SPECIFICITY;
AUTOIMMUNE DISEASE;
AUTOIMMUNITY;
B LYMPHOCYTE;
CANCER IMMUNOTHERAPY;
CAREER;
CELL POPULATION;
CELL THERAPY;
DENDRITIC CELL;
DIABETIC PATIENT;
HEALTH CENTER;
HUMAN;
IMMUNOREGULATION;
INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
STEM CELL TRANSPLANTATION;
THERAPY EFFECT;
ANIMAL;
AUTOIMMUNE DISEASES;
HISTORY;
IMMUNOLOGY;
IMMUNOTHERAPY;
INTERVIEW;
PATHOLOGY;
PROCEDURES;
TRANSPLANTATION;
ARTICLE;
METHODOLOGY;
ANIMALS;
AUTOIMMUNE DISEASES;
DENDRITIC CELLS;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
IMMUNOTHERAPY;
|
|
EID: 84883591200
PISSN: 1750743X
EISSN: 17507448
Source Type: Journal
DOI: 10.2217/imt.13.89 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
